Home | Business News | Financial News | LGC Capital Announces Agreement to Acquire a Significant Interest in Fully Licenced European Pharmaceutical Company, Freia Farmaceutici Srl. LGC Capital Announces Agreement to Acquire a Significant Interest in Fully Licenced European Pharmaceutical Company, Freia Farmaceutici Srl. RecommendedHeirloom, CarbonCure Technologies and Central Concrete Achieve First-Ever Storage of Atmospheric CO2 Captured By Direct Air Capture In ConcreteInvestmentPitch Media Video Discusses Nextech AR Solutions and its Update of Spin-Out of its Generative AI Powered Toggle3D PlatformCanada’s Preeminent Industrial Filter Products Solution Provider Expands Into the US Market